Immediate Impact
1 by Nobel laureates 34 standout
Citing Papers
Multidrug-resistant tuberculosis
2024 Standout
From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
Works of Synne Jenum being referenced
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
2021
Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Synne Jenum | 321 | 237 | 120 | 33 | 446 | |
| F. Mengoni | 229 | 212 | 141 | 21 | 471 | |
| Jin Gu | 288 | 208 | 108 | 16 | 414 | |
| J. Suo | 278 | 245 | 149 | 21 | 476 | |
| Tongyang Xiao | 317 | 226 | 70 | 26 | 406 | |
| Jingtao Gao | 265 | 215 | 110 | 45 | 400 | |
| Guofang Deng | 312 | 236 | 133 | 54 | 475 | |
| Sergo Vashakidze | 330 | 237 | 158 | 20 | 482 | |
| Afsal Kolloli | 265 | 180 | 53 | 31 | 504 | |
| Daniel Eklund | 237 | 158 | 41 | 29 | 506 | |
| Elsa Du Bruyn | 333 | 207 | 96 | 17 | 500 |
All Works
Loading papers...